Choate Investment Advisors Buys 905 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Choate Investment Advisors grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 61.8% during the fourth quarter, HoldingsChannel reports. The firm owned 2,370 shares of the medical equipment provider’s stock after purchasing an additional 905 shares during the quarter. Choate Investment Advisors’ holdings in Intuitive Surgical were worth $1,237,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Howard Capital Management Group LLC raised its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after acquiring an additional 92 shares in the last quarter. Principal Financial Group Inc. grew its stake in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares during the period. Impax Asset Management Group plc raised its holdings in Intuitive Surgical by 43.9% in the third quarter. Impax Asset Management Group plc now owns 5,167 shares of the medical equipment provider’s stock worth $2,538,000 after purchasing an additional 1,577 shares in the last quarter. Empowered Funds LLC lifted its position in Intuitive Surgical by 4.4% during the third quarter. Empowered Funds LLC now owns 8,177 shares of the medical equipment provider’s stock valued at $4,017,000 after buying an additional 345 shares during the period. Finally, Mizuho Securities USA LLC boosted its holdings in shares of Intuitive Surgical by 6.7% during the 3rd quarter. Mizuho Securities USA LLC now owns 29,180 shares of the medical equipment provider’s stock valued at $14,335,000 after buying an additional 1,835 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ISRG. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Raymond James raised their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Up 1.6 %

Shares of ISRG opened at $484.44 on Monday. The firm has a fifty day simple moving average of $567.46 and a two-hundred day simple moving average of $531.94. The firm has a market cap of $172.55 billion, a PE ratio of 75.58, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.